ArticleDrug safety2022

Authors' Reply to Mungmunpuntipantip et al.'s Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands".

Agnes Kant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.